Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Choudongning is a Traditional Chinese Medicine (TCM) capsule primarily indicated for the treatment of Tourette syndrome and various tic disorders in children. It is specifically formulated for patients exhibiting the TCM syndrome of phlegm stasis due to spleen deficiency. The drug is composed of multiple herbal ingredients designed to resolve phlegm, strengthen the spleen, and calm internal wind. Developed through a collaboration between Henan Qing Yang Industrial and the Tianjin University of Traditional Chinese Medicine, Choudongning has been evaluated in multi-center clinical trials where it demonstrated efficacy in reducing tic severity (as measured by the Yale Global Tic Severity Scale) comparable to conventional treatments like Tiapride, but with a more favorable safety profile regarding side effects such as sedation and extrapyramidal symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Choudongning.